CpG Island Methylation Panel
BisCap® Human CpG Island Panel is targeted for detection of methylation status of 27,000 CpG island and also covers 13 commercial methylation markers. The panel could be widely used in methylation mar...
iGeneTech: Ten years of evolution, all for better target gene enrichment, founded in Beijing in 2014, is a biotechnology company. With intellectual property rights, there are three major technology platforms: NGS probe hybridization, multiplex PCR primer design, and high-throughput oligo pools synthesis. A high-tech enterprise certified by ISO 13485 and ISO 9001 quality management systems, that provides customized gene capture products for fields such as tumor companion diagnosis, multi-cancer early detection, breeding chips, pathogen monitoring, etc.
BisCap® Human CpG Island Panel is targeted for detection of methylation status of 27,000 CpG island and also covers 13 commercial methylation markers. The panel could be widely used in methylation mar...
Based on tumor-informed assays, combined with independently developed hybridization capture systems and high-throughput MRD Panel synthesis, we have launched a comprehensive MRD hybridization capture ...
TargetSeq® Universal Blocking Oligo series products are used to block self-ligation of adapters to reduce non-specific adapter interaction during probe hybridization and thus to increase data utilizat...
IGT® Adapter & UDI Primers is a series of adapter & unique dual-indexed primer kits used for NGS library construction of dsDNA, ssDNA and methylation DNA. iGeneTech provides 384 combinations of differ...
iGeneTech® owns the independently developed TargetSeq® hybridization capture sequencing technology and IGT® Oligo Pools synthesis platform, which enable the design of products targeting exon regions a...
CRISPR off-target effect may result in anomalous insertions, deletions and translocation. It is critical to have a sensitive detection tool for the off-target editing. Based on the highly sensitive, a...
iGeneTech: Ten years of evolution, all for better target gene enrichment, founded in Beijing in 2014, is a biotechnology company. With intellectual property rights, there are three major technology platforms: NGS probe hybridization, multiplex PCR primer design, and high-throughput oligo pools synthesis. A high-tech enterprise certified by ISO 13485 and ISO 9001 quality management systems, that provides customized gene capture products for fields such as tumor companion diagnosis, multi-cancer early detection, breeding chips, pathogen monitoring, etc.
No. 1A Chaoqian Road, Science and Technology Park, Changping District, Room 701, Building 1, Beijing, Beijing 100000, CN
Website link